If you purchased any of the below products between 2005 and February 2025, please register your details with us.
RegisterOn 13 February 2025 class action proceedings were commenced in the High Court of New Zealand against Johnson & Johnson (New Zealand) Limited, JNTL Consumer Health (New Zealand) Limited, and Johnson & Johnson Pacific Pty Limited (collectively 'Johnson & Johnson') alleging that Johnson & Johnson manufactured and distributed oral cold and flu products containing Phenylephrine under the Codral, Sudafed and Benadryl brands that are ineffective at relieving the symptoms of cold and flu they were marketed to treat.
Group members in this class action are persons who purchased any of the below products between 2005 to February 2025. If this includes you, please register your details with us by visiting the registration page via the below link.
Benadryl PE Chesty Cough & Nasal Congestion
Benadryl Mucus Relief Plus Decongestant
Codral Cold & Flu
Codral Day & Night
Codral Night
Codral Cold & Flu (powder sachet)
Codral Mucus Cough + Cold (liquid medicine)
Codral Cold & Flu + Mucus Cough (powder sachet)
Codral Cold & Flu + Mucus Cough
Codral Decongestant
Codral Cold & Flu Sore Throat
Day & Night Cold & Flu + Cough Combination
Sudafed PE Nasal Decongestant
Sudafed PE Sinus + Allergy & Pain Relief
Sudafed PE Sinus + Anti inflammatory Pain Relief
Sudafed PE Sinus + Pain Relief
Sudafed PE Sinus + Pain Relief Day + Night
If you purchased any of the above products between 2005 to February 2025, please register your details with us by visiting the registration page via the below link.
JGA Saddler is committed to ensuring that everyone, regardless of their background or financial situation, has access to justice. We run our class actions in a way that means you are not exposed to any costs or financial risk, so joining a class action will cost you nothing.
The class action is being funded by Omni Bridgeway on a “no win, no pay” basis in accordance with the terms of a funding agreement or terms imposed by the Court. If the class action is successfully resolved and there is a recovery of compensation, Omni Bridgeway will be entitled to reimbursement of the costs of the class action that it has funded plus a commission from the judgment or settlement amount, pursuant to the terms of the funding agreement.
Further, group members do not have to pay anything if the class action is unsuccessful, as Omni Bridgeway agrees to pay any legal costs that might be awarded to Johnson & Johnson.
No. Group members do not have to pay anything in the event that the class action is unsuccessful, as Omni Bridgeway agrees to pay any legal costs that might be awarded to Johnson & Johnson.
Unfortunately, we are unable to provide a timeframe of how long the class action will take to resolve. Our objective will always be to act in the best interests of the group to ensure any resolution is reached as quickly as possible while ensuring the best outcome for group members.
A class action is a group proceeding comprised of seven or more people who have been wronged by an individual or corporation. These claims generally arise out of similar circumstances that allow the group an opportunity to be heard based on common issues of law or fact. These proceedings are often commenced by one lead litigant on behalf of the group.